| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 2 |
| 1 | BELIMUMAB | 2 |
| 2 | BIMEKIZUMAB | 2 |
| 3 | ACETAMINOPHEN | 1 |
| 4 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 5 | ADALIMUMAB | 1 |
| 6 | ALENDRONATE SODIUM | 1 |
| 7 | APREMILAST | 1 |
| 8 | AZATHIOPRINE | 1 |
| 9 | BLINATUMOMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARIFENACIN HYDROBROMIDE | 1 | 0.0012 |
| 1 | DICLOFENAC SODIUM AND MISOPROSTOL | 1 | 0.0002 |
| 2 | ZOLMITRIPTAN | 1 | 0.0001 |
| 3 | LUMACAFTOR AND IVACAFTOR | 1 | 0.0001 |
| 4 | BLINATUMOMAB | 1 | 0.0001 |
| 5 | BIMEKIZUMAB | 2 | 0.0001 |
| 6 | BELIMUMAB | 2 | 0.0001 |
| 7 | PROMETHAZINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | INTERFERON BETA-1B | 1 | 0.0001 |
| 9 | DORNASE ALFA | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 3 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 4 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 5 | Folate Analog [EPC] | 1 | 0.0000 |
| 6 | Vitamin A [EPC] | 1 | 0.0000 |
| 7 | Nicotinic Acid [EPC] | 1 | 0.0000 |
| 8 | Antidote [EPC] | 1 | 0.0000 |
| 9 | Non-Standardized Food Allergenic Extract [EPC] | 1 | 0.0000 |